Picture1.jpg
Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery Platforms Including Proof of Concept Data in Non-Human Primates
09 janv. 2023 08h30 HE | Tessera Therapeutics
RNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human primates following a single administrationRNA Gene Writing™ platform...